Bone marrow stromal cells from multiple myeloma patients uniquely induce bortezomib resistant NF-κB activity in myeloma cells
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-4598
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Bone marrow stromal cells from multiple myeloma patients uniquely induce bortezomib resistant NF-κB activity in myeloma cells ; volume:9 ; number:1 ; day:6 ; month:7 ; year:2010 ; pages:1-13 ; date:12.2010
Molecular cancer ; 9, Heft 1 (6.7.2010), 1-13, 12.2010
- Creator
-
Markovina, Stephanie
Callander, Natalie S.
O'Connor, Shelby L.
Xu, Guangwu
Shi, Yufang
Leith, Catherine P.
Kim, KyungMann
Trivedi, Parul
Kim, Jaehyup
Hematti, Peiman
Miyamoto, Shigeki
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1476-4598-9-176
- URN
-
urn:nbn:de:101:1-2021082806264472550507
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Markovina, Stephanie
- Callander, Natalie S.
- O'Connor, Shelby L.
- Xu, Guangwu
- Shi, Yufang
- Leith, Catherine P.
- Kim, KyungMann
- Trivedi, Parul
- Kim, Jaehyup
- Hematti, Peiman
- Miyamoto, Shigeki
- SpringerLink (Online service)
Other Objects (12)
New bortezomib-based combination therapy for elimination of myeloma cells
Pirh2 mediates the sensitivity of myeloma cells to bortezomib via canonical NF-κB signaling pathway
Glycogen Synthase Kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell death
Establishment of a bortezomib-resistant Chinese human multiple myeloma cell line: MMLAL
Microbial antigens-loaded myeloma cells enhance Th2 cell proliferation and myeloma clonogenicity via Th2–myeloma cell interaction
Metformin and FTY720 Synergistically Induce Apoptosis in Multiple Myeloma Cells
Lenalidomide vs bortezomib maintenance choice post-autologous hematopoietic cell transplantation for multiple myeloma
Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma
Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma
Bortezomib, lenalidomide, and dexamethasone (VRd) followed by autologous stem cell transplant for multiple myeloma
A feline case of multiple myeloma treated with bortezomib
YL064 directly inhibits STAT3 activity to induce apoptosis of multiple myeloma cells
New bortezomib-based combination therapy for elimination of myeloma cells
Pirh2 mediates the sensitivity of myeloma cells to bortezomib via canonical NF-κB signaling pathway
Glycogen Synthase Kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell death
Establishment of a bortezomib-resistant Chinese human multiple myeloma cell line: MMLAL
Microbial antigens-loaded myeloma cells enhance Th2 cell proliferation and myeloma clonogenicity via Th2–myeloma cell interaction
Metformin and FTY720 Synergistically Induce Apoptosis in Multiple Myeloma Cells
Lenalidomide vs bortezomib maintenance choice post-autologous hematopoietic cell transplantation for multiple myeloma
Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma
Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma
Bortezomib, lenalidomide, and dexamethasone (VRd) followed by autologous stem cell transplant for multiple myeloma
A feline case of multiple myeloma treated with bortezomib
YL064 directly inhibits STAT3 activity to induce apoptosis of multiple myeloma cells
New bortezomib-based combination therapy for elimination of myeloma cells
Pirh2 mediates the sensitivity of myeloma cells to bortezomib via canonical NF-κB signaling pathway
Glycogen Synthase Kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell death
Establishment of a bortezomib-resistant Chinese human multiple myeloma cell line: MMLAL
Microbial antigens-loaded myeloma cells enhance Th2 cell proliferation and myeloma clonogenicity via Th2–myeloma cell interaction
Metformin and FTY720 Synergistically Induce Apoptosis in Multiple Myeloma Cells
Lenalidomide vs bortezomib maintenance choice post-autologous hematopoietic cell transplantation for multiple myeloma
Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma
Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma
Bortezomib, lenalidomide, and dexamethasone (VRd) followed by autologous stem cell transplant for multiple myeloma
A feline case of multiple myeloma treated with bortezomib